Author name: Md Sabeeh Ahmad

Md Sabeeh Ahmad is an Analyst at SpicyIP and LLM Candidate at the University of Cambridge. He graduated from the Aligarh Muslim University, Aligarh and has keen interest in Access to Medicines and Health Policy. He can be reached at: [email protected]

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (April 21 – April 27)

A reminder on the SpicyIP Summer School, applications for which are now open! Some anomalies in the Patent Agent exam results, a twist in the PPL-Azure case before the Supreme Court, Kerala’s new IPR and TK Policy draft, and a lot more that has happened in the last week. Add to that – an upcoming post on the big Ustad FW Dagar vs. AR Rahman judgment from the Delhi High Court. Here’s a roundup of our blog posts, case summaries […]

SpicyIP Weekly Review (April 21 – April 27) Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (April 14 – April 20)

Sound recording licensing, India’a annual IP report, creative works as industrial design, and a lot more that has happened last week. Not to forget – SpicyIP Summer School is now accepting applications! As we near the end of April, here’s a roundup of our blog posts, case summaries and top IP developments in the country and the world this week. Anything we are missing out on? Drop a comment below to let us know. Highlights of the Week PPL Cannot

SpicyIP Weekly Review (April 14 – April 20) Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (April 7 – April 13)

Keep up with the ever changing world of IP with SpicyIP’s Weekly Review! In the second week of April we have a post looking closely at the Draft CRI Guidelines 2025 (deadline today for submitting comments!), a food for thought post asking: in a world where access to knowledge is increasingly sought, the question isn’t just who gets to read but also what gets read, and why? And an analysis of the Madras HC judgment in Kemin v. Controller of

SpicyIP Weekly Review (April 7 – April 13) Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (March 31 – April 6)

Keep up with the ever changing world of IP with SpicyIP’s Weekly Review! Beginning April with a three-part post exposing the alarming lack of transparency surrounding public funds spent on indigenously developed COVID-19 vaccines, a two part post on the latest Kunal Kamra controversy and its copyright implications, and the difficulty in getting cancer related information in India. This and much more in this week’s SpicyIP Weekly Review. Anything we are missing out on? Drop a comment below to let

SpicyIP Weekly Review (March 31 – April 6) Read More »

The Great Indian Cancer Information Treasure Hunt

[This post has been co-authored by Swaraj and Sabeeh. Long post ahead] Cancer incidences continue to increase in India, with over 1.46 million estimated new cases diagnosed annually as of 2022 and predicted to rise to 1.57 million cases by 2025 (More on these numbers later!). The continuous interaction of public health priorities with IP laws have been mainstream discussion for a long time now. To what extent exactly do IP laws create, shape, or impact the political economy of

The Great Indian Cancer Information Treasure Hunt Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (March 17 – March 23)

Keep up with the ever changing world of IP with SpicyIP’s Weekly Review! A quick glance at last week – the first instance of AI hallucination in a judicial order, Delhi HC’s order in PPL v. Azure that has further muddied already murky waters concerning the interplay between Sections 30 and 33 of the Copyright Act, and the Delhi HC ordering the removal of Zepto mark from the trademark registry. This and much more in this week’s SpicyIP Weekly Review.

SpicyIP Weekly Review (March 17 – March 23) Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (March 10 – March 16)

Keep up with the ever changing world of IP with SpicyIP’s Weekly Review! A quick glance at last week – finding the real “Burger King” saga continues now at the Supreme Court, ED’s involvement in the Shankar-Tamilnandan copyright case, right to health and compulsory licensing for rare disease medicine Risdiplam. This and much more in this week’s SpicyIP Weekly Review. Anything we are missing out on? Drop a comment below to let us know. Highlights Finding the Real “Burger King”:

SpicyIP Weekly Review (March 10 – March 16) Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (March 3 – March 9)

Keep up with the ever changing world of IP with SpicyIP’s Weekly Review! A quick glance at last week – analysis of wrongful obtainment in the Indian patent landscape, discussing Delhi High Court’s jurisdiction in ANI vs OpenAI, and the implications of a MoU between screen writers and music composers. This and much more in this week’s SpicyIP Weekly Review. Anything we are missing out on? Drop a comment below to let us know. Highlights Moving Towards a ‘Wrongful Obtainment’

SpicyIP Weekly Review (March 3 – March 9) Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (February 24 – March 2)

Keep up with the ever changing world of IP with SpicyIP’s Weekly Review! A quick glance at last week – analysis of a Delhi HC judgment on the patentability of genetically modified salmonella bacteria, a look at the Philips DVD Case where the Court imposed heavy damages and costs, and a post-grant opposition leading to a revocation of Optimus’ Linelizoid patent. This and much more in this week’s SpicyIP Weekly Review. Anything we are missing out on? Drop a comment

SpicyIP Weekly Review (February 24 – March 2) Read More »

Optimus’ Linezolid Patent Revoked After Post-Grant Opposition

The Indian Patent Office has revoked the Patent No. 281489 (Application No. 201641013830) subsequent to a post-grant opposition by Symed Labs. The patent was revoked for lacking obviousness/inventive step, not being a patentable invention under section 3(d) and failure to disclose requisite information under section 8 of the Patents Act. The patent was granted on 20 March, 2017 and the post grant opposition was filed on 5 March, 2018. The patent relates to Linezolid, an antibiotic primarily used against pneumonia, skin

Optimus’ Linezolid Patent Revoked After Post-Grant Opposition Read More »

Scroll to Top